Yahoo Finance

TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic

BOSTON, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, reported ...
Yahoo Finance

TransCode Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial

BOSTON, April 27, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a leading clinical-stage oncology company committed to using its proprietary delivery system platform to defeat ...
Morningstar

TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic

TransCode’s RIG-I agonist precursor comprises single-stranded 5’-uncapped biphosphate or triphosphate oligonucleotides having a sequence complementary to an endogenous microRNA. The precursor may be ...
Pharmabiz

TransCode gets US FDA nod to proceed with First-In-Human trial of TTX-MC138 to treat advanced solid tumours

TransCode Therapeutics, Inc., the RNA oncology company, announced that it has received written authorization from the US Food and Drug Administration (FDA) that it may proceed with its First-in-Human ...